Kidneys Home > Nexavar and Breastfeeding
Women who are nursing are generally advised to not take Nexavar (sorafenib). Although no studies have been done to determine if this drug passes through human breast milk, it does pass through breast milk in rats and could cause serious complications in a nursing baby. Before taking Nexavar while breastfeeding, talk to your healthcare provider about your options.
Can Breastfeeding Women Take Nexavar?Nexavar® (sorafenib) is a prescription chemotherapy medication used in the treatment of certain types of liver, thyroid, and kidney cancer. At this time, it is unknown whether this drug passes through breast milk in humans. The manufacturer recommends women not take Nexavar while breastfeeding.
More Information About Nexavar and BreastfeedingNexavar has not been studied in women who were breastfeeding. However, animal studies have shown that the drug does pass through the breast milk of rats.
Based on the properties of the medication, it is also likely to pass through human breast milk. However, because of the lack of research, it is unknown how much Nexavar would be found in the breast milk or if it would harm a nursing infant.
Nexavar is associated with potentially serious side effects, including:
Because of the potential for these Nexavar side effects in a nursing infant, it may be best to avoid breastfeeding while taking this medication.